Skip to main content
. 2020 Mar 4;11(4):935–942. doi: 10.1111/1759-7714.13378

Table 3.

Clinical efficacy data of osimertinib treatment

Treatment response All patients (n = 56) (%) 95% CI
CR 2 (3.6)
PR 32 (57.1)
SD 17 (30.4)
PD 4 (7.1)
NE 1 (1.8)
ORR (%) 34 (60.7) 46.8–73.5
DCR (%) 51 (91.1) 80.4–97.0

CI, confidence interval; CR, complete response; DCR, disease control rate; NE, not evaluated; ORR, objective response rate; PD, progressive disease; PR, partial response; SD, stable disease.